Centro de Investigaciones Médicas Mar del Plata SRL

Av. Colón 3083, Mar del Plata, Buenos Aires

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Ruth Alcazar

Sofia Sawczuk

Adrian Hernandez Gauna

Moira Alejandra Reig

Cecilia García

Alicia Testa

Arturo Barbero

Pablo Martinez Monferrán

Juan Alvarisqueta

Adriana Andrada

Erica Sosa

Alejandro Julio Pereyra

Alejandro J. Pereyra

Jose Luis Taborda

Carolina Iturralde

Natalia De Gennaro

Germana María Figueroa

Eliana Sofía Perez

Andrés Alvarisqueta

Jessica De Gennaro

Paula Carucci

Gabriela Loreta Moran Faienzo

Open studies

Gastroesophageal cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Destiny-Gastric05 - Merck Sharp & Dohme LLC

Heart failure

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZeneca

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer Ingelheim

Renal disease

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZeneca

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease - NN C0519-0130 - Novo Nordisk A/S

Bile Duct Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Breast Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Cervical cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Colorectal cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Diabetes

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI) - MicuRx

Endometrial Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Esophageal cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Fatty Liver

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Fatty liver/nash

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Gastric cancer

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Destiny-Gastric05 - Merck Sharp & Dohme LLC

Gastrointestinal Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Head and neck cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Liver Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Lupus

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - AMETHYST - Biogen

Ovarian cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Pancreatic cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Prurigo nodularis

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) - STOP-PN1 - Incyte Corporation

Rare diseases

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome - Unity - argenx

Skin cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Solid tumors

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Urothelial cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads

Centro de Investigaciones Médicas Mar del Plata SRL

Av. Colón 3083, Mar del Plata, Buenos Aires

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Ruth Alcazar

Sofia Sawczuk

Adrian Hernandez Gauna

Moira Alejandra Reig

Cecilia García

Alicia Testa

Arturo Barbero

Pablo Martinez Monferrán

Juan Alvarisqueta

Adriana Andrada

Erica Sosa

Alejandro Julio Pereyra

Alejandro J. Pereyra

Jose Luis Taborda

Carolina Iturralde

Natalia De Gennaro

Germana María Figueroa

Eliana Sofía Perez

Andrés Alvarisqueta

Jessica De Gennaro

Paula Carucci

Gabriela Loreta Moran Faienzo

Open studies

Gastroesophageal cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Destiny-Gastric05 - Merck Sharp & Dohme LLC

Heart failure

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZeneca

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer Ingelheim

Renal disease

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZeneca

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease - NN C0519-0130 - Novo Nordisk A/S

Bile Duct Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Breast Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Cervical cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Colorectal cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Diabetes

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI) - MicuRx

Endometrial Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Esophageal cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Fatty Liver

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Fatty liver/nash

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Gastric cancer

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Destiny-Gastric05 - Merck Sharp & Dohme LLC

Gastrointestinal Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Head and neck cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Liver Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Lupus

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - AMETHYST - Biogen

Ovarian cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Pancreatic cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Prurigo nodularis

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) - STOP-PN1 - Incyte Corporation

Rare diseases

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome - Unity - argenx

Skin cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Solid tumors

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

Urothelial cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - IDeate-PanTumor02 - Merck Sharp & Dohme LLC

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads